Senti Biosciences, Inc. (SNTI)
1.22
-0.09
(-6.87%)
USD |
NASDAQ |
Dec 15, 15:28
Senti Biosciences Shareholders Equity (Quarterly): 8.121M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| iBio, Inc. | 56.04M |
| Vor Biopharma, Inc. | -2.225B |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
| Palatin Technologies, Inc. | 0.3964M |
| Theriva Biologics, Inc. | 6.738M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 52.68M |
| Total Liabilities (Quarterly) | 44.56M |
| Debt to Equity Ratio | 3.709 |
| Current Ratio | 1.510 |
| Net Debt Paydown Yield | 3.03% |